CAR T and CAR NK cells in multiple myeloma: Expanding the targets Review


Authors: Shah, U. A.; Mailankody, S.
Review Title: CAR T and CAR NK cells in multiple myeloma: Expanding the targets
Abstract: Multiple myeloma (MM) is a haematologic malignancy with significant improvements in the overall survival over the last decade. However, patients still relapse and die due to a lack of treatment options. Ultimately, novel therapies with the potential for long term remissions are needed for patients with advanced MM. Research efforts for such immune therapies were not successful until recently when the first immunotherapies for MM were approved in 2015 and many more are under development. In this review, we focus on adoptive cell therapies including CAR T-cell and CAR NK-cell therapies for patients with MM. We will provide an update on clinical and translational advances with a focus on results from ongoing clinical trials with BCMA targeted cellular therapies and the development of other novel targets, changes in the manufacturing process, trials focusing on earlier lines of therapy and combinations with other therapies as well as off the shelf products. © 2020
Keywords: unclassified drug; review; t lymphocyte; multiple myeloma; immunoglobulin kappa chain; g protein coupled receptor; adoptive immunotherapy; cd19 antigen; single chain fragment variable antibody; natural killer cell receptor nkg2d; syndecan 1; randomized controlled trial (topic); phase 2 clinical trial (topic); phase 3 clinical trial (topic); phase 1 clinical trial (topic); cd56 antigen; lymphocyte antigen; chimeric antigen receptors; human; priority journal; b cell maturation antigen; adp ribosyl cyclase/cyclic adp ribose hydrolase 1; b-cell maturation antigen; car t-cell therapy; g protein coupled receptor class c group 5 member d; signalling lymphocytic activation molecule family 7
Journal Title: Best Practice and Research: Clinical Haematology
Volume: 33
Issue: 1
ISSN: 1521-6926
Publisher: Elsevier Inc.  
Date Published: 2020-03-01
Start Page: 101141
Language: English
DOI: 10.1016/j.beha.2020.101141
PUBMED: 32139020
PROVIDER: scopus
PMCID: PMC7137578
DOI/URL:
Notes: Review -- Export Date: 1 April 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Urvi A Shah
    187 Shah